Erfolg Life Sciences Private Limited was founded in July 2105 by Ramesh Meesala. It is a Healthcare Analytics company that using its flagship product, MedRep™, integrates all the Indian Healthcare users onto a common Digital Healthcare Platform, to enable seamless interactions amongst the users and parallelly, offer Healthcare organizations comprehensive and business critical insights into the market functioning.
Presently, the application is live both on Google’s Playstore (
Android) and Apple Store (
iOS).
Team BWDisrupt Interacts With Ramesh Meesala, Founder, Erfolg And Spoke To Him How did the idea came to start? MedRep™, is a direct result of Erfolg’s leadership team’s decades worth of experience within Indian and Global Healthcare space. With an in depth understanding of the Indian Healthcare industry’s challenges.
How does Erfolg work? MedRep™ Mobile Application, interconnects, Pharmaceutical companies to Doctors, Pharmacies & Patients, with each of the users receiving a separate set of functionalities and features, that result in business critical marketing insights and health outcomes.
To start off this chain, we have connected the Pharmaceutical Companies to Doctors, where Pharmaceutical companies can:
i. Promote their newly released products to Doctors directly on the doctor’s mobile devices
ii. Send Marketing and Industry related Surveys to doctor to fill out
iii. Monitor and plan medical representative appointments
iv. Track and analyze the efficacy of their product marketing campaigns
As an end objective of this Digital Healthcare Platform, Erfolg intends to target the following key areas:
i. Healthcare Analytics for the Healthcare Companies
ii. Negating the Counterfeit Drug market in India
iii. Prescription Tracking and Analysis
How are you different from the existing ones? Most of the applications out there cater to connecting only Doctors and Patients. But, MedRep™, is the only platform that puts Healthcare companies such as, Pharmaceutical Companies, Biotechnology companies and Medical Device Manufacturing companies at the epicenter of the healthcare ecosystem, and assists in bringing order to chaos in the currently turbulent Indian healthcare market.
Funding status We have not raised any funds till now and we are in a process of raising $650,000 as part of the pre series A funding.
MonetizationOur primary customers are Healthcare companies, so we charge them based per Product Notification per Doctor.
Challenges faced Identifying and building the team towards the development of the product were some of the hurdles that we faced prior to our release of the first version of the application.
Present status and future plans We have very recently launched our application onto the respective iOS and Android Stores. We have started our beta with a Pharmaceutical Company and a Medical Device Manufacturing company to promote their products to therapeutically aligned Doctors. The plan is have 25,000 Doctors with 5 to 6 Pharmaceutical Companies for the year 2016.
Market Opportunity Currently, there are more than 5000 Pharmaceutical Companies in India, that collectively manufacture close to 90,000 products and market it to approximately 8,00,000 registered and practicing doctors in India. The market opportunity is around $4 billion.
